The US biotechnology company Moderna plans to develop vaccines that can work against cancer by 2030. That’s what Moderna’s chief medical officer, Paul Burton, told the British “Guardian“. The vaccines will also be available for cardiovascular, autoimmune and other diseases, Burton said.
He believes Moderna will be able to bring personalized cancer vaccines to people around the world against multiple different types of tumors. In doing so, he hopes to save “hundreds of thousands, if not millions, of lives.”
However, it is not yet to be expected that the vaccines will completely replace current cancer therapies. They should act as a supplement.
Biontech also reports on advances in research
Biontech co-founder Uğur Şahin also made an appearance opposite the mirror optimistic as early as February when he reported on the progress made in research into cancer vaccines.
Biontech first wants to develop a drug against testicular cancer. By 2027, the company would then like to launch several products as cancer therapies, provided the studies are successful. That said the head of the supervisory board, Helmut Jeggle the Augsburger Allgemeine Zeitung.
As with the corona vaccines, both companies use mRNA technology. This is intended to identify the cancer cells in the body and then destroy them.
Moderna achieved initial success in the fight against melanoma last December with an mRNA vaccine. In combination with another cancer drug, the risk of dying or falling ill within a certain period of time fell by about 44 percent in patients.
In the development phase, mRNA technology for cancer vaccines can only be used in people who already have cancer.
To home page